7246 related articles for article (PubMed ID: 15893279)
1. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Markowitz J; Grancher K; Mandel F; Daum F
Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
5. Managing the glucocorticoid dependent inflammatory bowel disease patient.
Bonner GF
Semin Gastrointest Dis; 2001 Oct; 12(4):237-44. PubMed ID: 11726077
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL
Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632
[TBL] [Abstract][Full Text] [Related]
7. General principles of medical therapy of inflammatory bowel disease.
Friedman S
Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
[TBL] [Abstract][Full Text] [Related]
8. Medical management of patients with difficult-to-treat inflammatory bowel disease.
van Hogezand RA
Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
[TBL] [Abstract][Full Text] [Related]
9. [Treatment strategies for inflammatory bowel disease].
Lémann M; Allez M
Rev Prat; 2005 May; 55(9):984-92. PubMed ID: 16052969
[TBL] [Abstract][Full Text] [Related]
10. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
[TBL] [Abstract][Full Text] [Related]
11. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
12. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach--EPACT.
Vader JP; Froehlich F; Juillerat P; Burnand B; Felley C; Gonvers JJ; Mottet C; Pittet V; Dubois RW; Wietlisbach V; Michetti P
Digestion; 2006; 73(4):237-48. PubMed ID: 16940727
[TBL] [Abstract][Full Text] [Related]
13. Review article: chronic active disease and maintaining remission in Crohn's disease.
Kamm MA
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease: current therapeutic options.
Domènech E
Digestion; 2006; 73 Suppl 1():67-76. PubMed ID: 16498254
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacotherapy of inflammatory bowel disease].
Jojić N
Acta Chir Iugosl; 2000; 47(1-2):51-5. PubMed ID: 10953366
[TBL] [Abstract][Full Text] [Related]
16. Optimizing therapy for inflammatory bowel disease.
Robinson M
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
Aranda R; Horgan K
Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of medically induced remission of Crohn's disease.
Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
[TBL] [Abstract][Full Text] [Related]
19. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease: management issues during pregnancy.
Ferrero S; Ragni N
Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]